Yahoo Web Search

Search results

1. • 

     Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition

     Investing.com· 1 day ago

     The earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...

2. • AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates

     Guru Focus· 4 days ago

     On April 26, 2024, AbbVie Inc (ABBV, Financial) released its 8-K filing, detailing the financial outcomes for the first quarter ended March 31, 2024. The pharmaceutical giant reported a diluted ...

3. • AbbVie Reports First-Quarter 2024 Financial Results

     Hometownsource.com· 4 days ago

     Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable

4. • 

     AbbVie Is 'Firing On All Cylinders,' But Its Stock Isn't

     Investor's Business Daily· 4 days ago

     Shares tumbled despite a first-quarter beat and earnings guidance increase.

5. • AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...

     GuruFocus.com via Yahoo Finance· 3 days ago

     So our market share continues to be strong and stable. For Botox Cosmetic, despite a new competitor, strong stable share at high levels. And then for our Juvederm line, continued ...

6. • Q1 2024 AbbVie Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 3 days ago

     We also gained U.S. approval of Juvederm Voluma XC for temple hollows, further strengthening our leadership in aesthetic fillers. And we executed several business development ...

7. • Tampa Area Dentist, Dr. Luz, Now Providing Facial Aesthetics

     PRWeb· 5 days ago

     Dr. Luz believes in continuing education, consistently expanding her knowledge and training in her current field and additional specialty fields. As a dedicated dentist for over a decade, Dr ...